Literature DB >> 7646475

Glutamate stably enhances the activity of two cytosolic forms of phospholipase A2 in brain cortical cultures.

D K Kim1, G Rordorf, R A Nemenoff, W J Koroshetz, J V Bonventre.   

Abstract

The mechanisms by which glutamatergic neurotransmitters modulate neuronal lipid metabolism are not well established. We have directly measured phospholipase A2 (PLA2) enzymic activity in cell-free extracts from cortical neuronal cultures from rat brain and have found that the PLA2 activity is up-regulated after cells are exposed to glutamate. Brief exposure to a calcium ionophore or phorbol 12-myristate 13-acetate (PMA) stably enhanced PLA2 activity. Down-regulation of protein kinase C activity partially blocked glutamate's effects. Two Ca(2+)-and pH-dependent forms of PLA2 were identified in cytosolic extracts. Activation of both forms of PLA2 was enhanced by prior exposure of the cultures to glutamate. One of the two forms had chromatographic characteristics on heparin-Sepharose, Mono Q and Superose 12 columns similar to the 100 kDa cytosolic PLA2 (cPLA2), and was recognized by an antibody raised to pig spleen cPLA2. The second form was similar in size to Group-I and -II PLA2s but differed in chromatographic characteristics. It was not inhibited by dithiothreitol, and did not react with antibodies to pancreatic Group-I PLA2, features that distinguish it from Group-I and -II PLA2. In extracts from cells pretreated with glutamate, the activity-Ca2+ concentration dose-response relationship of the 13.5 kDa form of PLA2 was shifted to the left with activation at lower Ca2+ concentration as the result of stable modification of the enzyme induced by glutamate. Thus glutamate-induced stable enhancement of PLA2 activity, by processes involving calcium and protein kinase C activation, is a potential molecular switch probably mediating changes in synaptic function and contributing to excitotoxicity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7646475      PMCID: PMC1135857          DOI: 10.1042/bj3100083

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  50 in total

Review 1.  Arachidonic acid cascade and signal transduction.

Authors:  T Shimizu; L S Wolfe
Journal:  J Neurochem       Date:  1990-07       Impact factor: 5.372

2.  Detection and subcellular localization of rabbit platelet phospholipase A2 which preferentially hydrolyzes an arachidonoyl residue.

Authors:  D K Kim; I Kudo; Y Fujimori; H Mizushima; M Masuda; R Kikuchi; K Ikizawa; K Inoue
Journal:  J Biochem       Date:  1990-12       Impact factor: 3.387

3.  Exposure to N-methyl-D-aspartate increases release of arachidonic acid in primary cultures of rat hippocampal neurons and not in astrocytes.

Authors:  C Sanfeliu; A Hunt; A J Patel
Journal:  Brain Res       Date:  1990-09-03       Impact factor: 3.252

4.  Purification of a high-molecular-mass form of phospholipase A2 from rat kidney activated at physiological calcium concentrations.

Authors:  J H Gronich; J V Bonventre; R A Nemenoff
Journal:  Biochem J       Date:  1990-10-01       Impact factor: 3.857

5.  Subcellular characteristics of phospholipase A2 activity in the rat kidney. Enhanced cytosolic, mitochondrial, and microsomal phospholipase A2 enzymatic activity after renal ischemia and reperfusion.

Authors:  H Nakamura; R A Nemenoff; J H Gronich; J V Bonventre
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

6.  Presynaptic changes in long-term potentiation: elevated synaptosomal calcium concentration and basal phosphoinositide turnover in dentate gyrus.

Authors:  M A Lynch; K L Voss
Journal:  J Neurochem       Date:  1991-01       Impact factor: 5.372

7.  Transfected D2 dopamine receptors mediate the potentiation of arachidonic acid release in Chinese hamster ovary cells.

Authors:  R Y Kanterman; L C Mahan; E M Briley; F J Monsma; D R Sibley; J Axelrod; C C Felder
Journal:  Mol Pharmacol       Date:  1991-03       Impact factor: 4.436

8.  Recovery of postischemic brain metabolism and function following treatment with a free radical scavenger and platelet-activating factor antagonists.

Authors:  D D Gilboe; D Kintner; J H Fitzpatrick; S E Emoto; A Esanu; P G Braquet; N G Bazan
Journal:  J Neurochem       Date:  1991-01       Impact factor: 5.372

9.  Arachidonic acid released from striatal neurons by joint stimulation of ionotropic and metabotropic quisqualate receptors.

Authors:  A Dumuis; J P Pin; K Oomagari; M Sebben; J Bockaert
Journal:  Nature       Date:  1990-09-13       Impact factor: 49.962

10.  Seizure-like activity and glutamate receptors in hippocampal neurons in culture.

Authors:  W J Koroshetz; E J Furshpan
Journal:  Neurosci Res Suppl       Date:  1990
View more
  17 in total

1.  Lipid-dependent modulation of Ca2+ availability in isolated mossy fiber nerve endings.

Authors:  M L Ruehr; L Zhang; R V Dorman
Journal:  Neurochem Res       Date:  1997-10       Impact factor: 3.996

2.  Receptor-specific inhibition of GABAB-activated K+ currents by muscarinic and metabotropic glutamate receptors in immature rat hippocampus.

Authors:  Jong-Woo Sohn; Doyun Lee; Hana Cho; Wonil Lim; Hee-Sup Shin; Suk-Ho Lee; Won-Kyung Ho
Journal:  J Physiol       Date:  2007-01-25       Impact factor: 5.182

3.  Differential effects of polyunsaturated fatty acids on membrane capacitance and exocytosis in rat pheochromocytoma-12 cells.

Authors:  Wee-Liat Ong; Bin Jiang; Ning Tang; Su-Fung Ling; Jin-Fei Yeo; Shunhui Wei; Akhlaq A Farooqui; Wei-Yi Ong
Journal:  Neurochem Res       Date:  2006-01       Impact factor: 3.996

Review 4.  The role of secretory phospholipase A₂ in the central nervous system and neurological diseases.

Authors:  Tatsurou Yagami; Yasuhiro Yamamoto; Hiromi Koma
Journal:  Mol Neurobiol       Date:  2013-10-10       Impact factor: 5.590

Review 5.  Phospholipases A2 in ischemic and toxic brain injury.

Authors:  A Sapirstein; J V Bonventre
Journal:  Neurochem Res       Date:  2000-05       Impact factor: 3.996

Review 6.  Low molecular weight phospholipases A2 in mammalian brain and neural cells: roles in functions and dysfunctions.

Authors:  Gianfrancesco Goracci; Monica Ferrini; Vincenza Nardicchi
Journal:  Mol Neurobiol       Date:  2010-03-19       Impact factor: 5.590

7.  Characterizing phospholipase A2-induced spinal cord injury-a comparison with contusive spinal cord injury in adult rats.

Authors:  Nai-Kui Liu; William Lee Titsworth; Yi Ping Zhang; Aurela I Xhafa; Christopher B Shields; Xiao-Ming Xu
Journal:  Transl Stroke Res       Date:  2011-12-01       Impact factor: 6.829

8.  Cytosolic phospholipase A2 alpha inhibition prevents neuronal NMDA receptor-stimulated arachidonic acid mobilization and prostaglandin production but not subsequent cell death.

Authors:  Ava L Taylor; Joseph V Bonventre; Tracy F Uliasz; James A Hewett; Sandra J Hewett
Journal:  J Neurochem       Date:  2008-06-28       Impact factor: 5.372

9.  Differential effects of lysophospholipids on exocytosis in rat PC12 cells.

Authors:  May-Thu Ma; Jin-Fei Yeo; Akhlaq A Farooqui; Jing Zhang; Peng Chen; Wei-Yi Ong
Journal:  J Neural Transm (Vienna)       Date:  2010-03       Impact factor: 3.575

10.  Chronic administration of valproic acid reduces brain NMDA signaling via arachidonic acid in unanesthetized rats.

Authors:  Mireille Basselin; Lisa Chang; Mei Chen; Jane M Bell; Stanley I Rapoport
Journal:  Neurochem Res       Date:  2008-05-07       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.